FDA Drug Application (020918) for GLUCAGEN by NOVO NORDISK

Back to FDA Applications sponsored by NOVO NORDISK

Application Number020918
Product Number001
FormINJECTABLE;INJECTION
DosageEQ 1MG BASE/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameGLUCAGEN
Active IngredientGLUCAGON HYDROCHLORIDE RECOMBINANT



Back to FDA Applications sponsored by NOVO NORDISK